CENFLOXAZINE

Cenfloxacin is a fluoroquinolone inhibiting DNA gyrase, used for bacterial infections. Side effects include tendonitis, GI upset, and CNS symptoms.

SKU: d9d9b4d64c77 Category: Tag:

Product Description


Mechanism of Action

Cenfloxacin is a synthetic fluoroquinolone antibacterial that inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV—enzymes required for supercoiling, replication, transcription, and segregation of bacterial DNA. By stabilizing the DNA–enzyme cleavage complex, cenfloxacin induces lethal double‑strand breaks in replicating bacterial cells, leading to rapid bactericidal activity, especially against gram‑negative organisms.

Benefits and Advantages

Used in quinolone-resistance modelling, gyrase-target structural studies, bacterial DNA-replication assays, gram‑negative susceptibility research, PK/PD optimisation simulations, and fluoroquinolone SAR investigations. Helpful for studying quinolone binding pockets, QRDR mutations, and efflux‑pump–mediated resistance.

Side Effects and Risks

Risks include phototoxicity, QT prolongation, tendon injury, CNS stimulation (seizure risk), dysbiosis, and hepatotoxicity. Handle with strict antibacterial‑compound precautions.

Datasheet


Molecular Formula

C17H19FN2O2

Molecular Weight

302.35 g/mol

CAS Number

55987-18-7

Storage Condition

Store in a cool, dry place; protected from light

Solubility

Soluble in water

Purity

Purity information is available upon request (COA).

IUPAC/Chemical Name

1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(pyrrolidin-1-ylmethyl)quinoline-3-carboxylic acid

InChl Key

OIWPHESVZQYNPB-UHFFFAOYSA-N

References

PubChem; ChemBL; FDA substance registry;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download